Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arcangelo Liso

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Blood Advances|March 19, 2025
Prognostic role of interim PET in follicular lymphoma: a post hoc study of FOLL12 trial by Fondazione Italiana LinfomiRexhep Durmo, Stephane Chauvie, Federico Fallanca, et al.
Haematologica|July 8, 2008
A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1)Arcangelo Liso, Filippo Castiglione, Antonio Cappuccio, et al.
Blood|December 4, 2004
Tumor protein D52 (TPD52): a novel B-cell/plasma-cell molecule with unique expression pattern and Ca(2+)-dependent association with annexin VIEnrico Tiacci, Pier-Luigi Orvietani, Barbara Bigerna, et al.
Blood|July 17, 2010
CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised miceMaria Paola Martelli, Valentina Pettirossi, Christian Thiede, et al.
British Journal of Haematology|June 11, 2025
Copanlisib in combination with rituximab and bendamustine for transplant-ineligible relapsed/refractory diffuse large B-cell lymphoma patients: Results from the phase II multicentre FIL Copa-BR trial from Fondazione Italiana Linfomi (FIL)Mattia Novo, Pio Manlio Mirko Frascione, Alessia Castellino, et al.
Blood|May 25, 2006
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemiaBrunangelo Falini, Maria Paola Martelli, Niccolò Bolli, et al.
The New England Journal of Medicine|June 14, 2011
BRAF mutations in hairy-cell leukemiaEnrico Tiacci, Vladimir Trifonov, Gianluca Schiavoni, et al.
Genes, Chromosomes & Cancer|December 23, 2022
circPVT1 and PVT1/AKT3 show a role in cell proliferation, apoptosis, and tumor subtype-definition in small cell lung cancerDoron Tolomeo, Debora Traversa, Santina Venuto, et al.
Blood|October 21, 2011
Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotypeVera Grossmann, Enrico Tiacci, Antony B Holmes, et al.
Blood Advances|January 7, 2026
Real-World Safety and Effectiveness of Zanubrutinib versus Ibrutinib in CLL: The CLL-ZANU2024 Italian CohortEnrica Antonia Martino, Annalisa Pitino, Ernesto Vigna, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Blood Advances|March 19, 2025
Prognostic role of interim PET in follicular lymphoma: a post hoc study of FOLL12 trial by Fondazione Italiana LinfomiRexhep Durmo, Stephane Chauvie, Federico Fallanca, et al.
Haematologica|July 8, 2008
A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1)Arcangelo Liso, Filippo Castiglione, Antonio Cappuccio, et al.
Blood|December 4, 2004
Tumor protein D52 (TPD52): a novel B-cell/plasma-cell molecule with unique expression pattern and Ca(2+)-dependent association with annexin VIEnrico Tiacci, Pier-Luigi Orvietani, Barbara Bigerna, et al.
Blood|July 17, 2010
CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised miceMaria Paola Martelli, Valentina Pettirossi, Christian Thiede, et al.
British Journal of Haematology|June 11, 2025
Copanlisib in combination with rituximab and bendamustine for transplant-ineligible relapsed/refractory diffuse large B-cell lymphoma patients: Results from the phase II multicentre FIL Copa-BR trial from Fondazione Italiana Linfomi (FIL)Mattia Novo, Pio Manlio Mirko Frascione, Alessia Castellino, et al.
Blood|May 25, 2006
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemiaBrunangelo Falini, Maria Paola Martelli, Niccolò Bolli, et al.
The New England Journal of Medicine|June 14, 2011
BRAF mutations in hairy-cell leukemiaEnrico Tiacci, Vladimir Trifonov, Gianluca Schiavoni, et al.
Genes, Chromosomes & Cancer|December 23, 2022
circPVT1 and PVT1/AKT3 show a role in cell proliferation, apoptosis, and tumor subtype-definition in small cell lung cancerDoron Tolomeo, Debora Traversa, Santina Venuto, et al.
Blood|October 21, 2011
Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotypeVera Grossmann, Enrico Tiacci, Antony B Holmes, et al.
Blood Advances|January 7, 2026
Real-World Safety and Effectiveness of Zanubrutinib versus Ibrutinib in CLL: The CLL-ZANU2024 Italian CohortEnrica Antonia Martino, Annalisa Pitino, Ernesto Vigna, et al.
Pageof 10